Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
The first evidence that selective activation of the dentate gyrus in the hippocampus can reduce anxiety without affecting learning - important therapeutic implications.
A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke.
CUMC's Dr. Michael Terman will join ABC's Dr. Richard Besser during a live Twitter chat on winter depression and seasonal affective disorder December 11, 1 p.m.